X0202 SCHEDULE 13G 0001781002 XXXXXXXX LIVE Class A Common Shares 03/31/2026 0001840877 ENVOY MEDICAL, INC. 29415V109 4875 WHITE BEAR PARKWAY WHITE BEAR LAKE MN 55110 Rule 13d-1(b) Bleichroeder LP DE 7839000 0 7839000 0 7839000 N 9.99 IA Bleichroeder Holdings LLC DE 7839000 0 7839000 0 7839000 N 9.99 HC Andrew Gundlach X1 7839000 0 7839000 0 7839000 N 9.99 HC ENVOY MEDICAL, INC. 4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE, MN 55110 Bleichroeder Holdings LLC Bleichroeder LP Andrew Gundlach 1345 Avenue of the Americas, 47th Floor New York, NY 10105 Bleichroeder Holdings LLC and Bleichroeder LP: Delaware, USA Andrew Gundlach: United States N IA HC See cover page. See cover page. See cover page. See cover page. See cover page. See cover page. Y N N Bleichroeder LP ("Bleichroeder"), an investment adviser registered under Section 203 of the Investment Advisers Act of 1940, is deemed to be the beneficial owner of 7,839,000 shares, or 9.99%, of the Class A common stock (the "Common Stock") of Envoy Medical Corporation (the "Issuer") reported by the Issuer as outstanding. The 7,839,000 shares include 6,250,000 shares of Common Stock and 1,589,000 shares of Common Stock issuable upon exercise of warrants. In accordance with the Warrant Agreement, exercise of the warrants is subject to a Beneficial Ownership Limitation (as defined in the agreement) of 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise. Bleichroeder is the beneficial owner of Common Stock and warrants with a 9.99% limitation on the exercise of such warrants. If there were no 9.99% limitation on the exercise of such warrants, Bleichroeder would be deemed to be the beneficial owner of 16,250,000 shares of Common Stock, consisting of 6,250,000 shares of Common Stock and 10,000,000 shares of Common Stock issuable upon exercise of warrants, representing approximately 18.7% of the outstanding shares of Common Stock. Clients of Bleichroeder have the right to receive and the ultimate power to direct the receipt of dividends from, or the proceeds of the sale of, such securities. N See Exhibit 99.2 Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Exhibit 99.1 AGREEMENT OF THE REPORTING PERSONS Exhibit 99.2 JOINT FILING AGREEMENT Bleichroeder LP Andrew Gundlach 05/14/2026 Bleichroeder Holdings LLC Andrew Gundlach 05/14/2026 Andrew Gundlach Andrew Gundlach 05/14/2026